Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2003

01-02-2003 | Letter

The diagnosis and management of pre-invasive breast disease: editor's reply

Author: Sunil R Lakhani

Published in: Breast Cancer Research | Issue 1/2003

Login to get access

Excerpt

The letter from Badve [1] relating to the series on pre-invasive breast disease, published in the September and November issues of Breast Cancer Research [2‐10], is timely and very welcome. It rightly points out that one should be careful in changing classification systems based on limited knowledge and that perhaps discarding the term atypical ductal hyperplasia at the present time may be premature. I completely agree with him; however, there are a few issues I feel obliged to clarify. …
Literature
1.
Badve S: The diagnosis and management of pre-invasive breast disease: another point of view. Breast Cancer Res. 2004, 6: E3-10.1186/bcr740.CrossRefPubMed
2.
3.
Pinder SE, Ellis IO: The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH) – current definitions and classification. Breast Cancer Res. 2003, 5: 254-257. 10.1186/bcr623.CrossRefPubMedPubMedCentral
4.
Simpson PT, Gale T, Fulford LG, Reis-Filho JS, Lakhani SR: The diagnosis and management of pre-invasive breast disease: pathology of atypical lobular hyperplasia and lobular carcinoma in situ. Breast Cancer Res. 2003, 5: 258-262. 10.1186/bcr624.CrossRefPubMedPubMedCentral
5.
Schnitt SJ: The diagnosis and management of pre-invasive breast disease: flat epithelial atypia – classification, pathologic features and clinical significance. Breast Cancer Res. 2003, 5: 263-268. 10.1186/bcr625.CrossRefPubMedPubMedCentral
6.
van de Vijver MJ, Peterse H: The diagnosis and management of pre-invasive breast disease: pathological diagnosis – problems with existing classifications. Breast Cancer Res. 2003, 5: 269-275. 10.1186/bcr629.CrossRefPubMedPubMedCentral
7.
Nerurkar A, Osin P: The diagnosis and management of pre-invasive breast disease: the role of new diagnostic techniques. Breast Cancer Res. 2003, 5: 305-308. 10.1186/bcr721.CrossRefPubMedPubMedCentral
8.
Purushotham AD: The diagnosis and management of pre-invasive breast disease: problems associated with management of pre-invasive lesions. Breast Cancer Res. 2003, 5: 309-312. 10.1186/bcr649.CrossRefPubMedPubMedCentral
9.
Reis-Filho JS, Lakhani SR: The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions. Breast Cancer Res. 2003, 5: 313-319. 10.1186/bcr650.CrossRefPubMedPubMedCentral
10.
Jeffrey SS, Pollack JR: The diagnosis and management of pre-invasive breast disease: the promise of new technologies in understanding pre-invasive lesions. Breast Cancer Res. 2003, 5: 320-328. 10.1186/bcr655.CrossRefPubMedPubMedCentral
11.
World Health Organisation: World Health Organisation Classification of Tumours. Tumours of the Breast and Female Genital Organs. Edited by: Tavassoli FA, Devilee P. 2003, Lyon, France: IARC Press
Metadata
Title
The diagnosis and management of pre-invasive breast disease: editor's reply
Author
Sunil R Lakhani
Publication date
01-02-2003
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 1/2003
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr741

Other articles of this Issue 1/2003

Breast Cancer Research 1/2003 Go to the issue

Review

Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy

Article selection

Articles selected from Faculty of 1000 in November 2003

Commentary

Are BRCA1- and BRCA2-related breast cancers associated with increased mortality?

Review

Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes

Meeting report

AACR Special Conference: Advances in Breast Cancer Research – Genetics, Biology, and Clinical Implications, Huntington Beach, California, USA, 8–12 October 2003

Commentary

Prevention of breast cancer by recapitulation of pregnancy hormone levels
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits